biogrithm

What biogrithm does

Biogrithm Bioinformatics Company Pvt Ltd is an India-based, privately held bioinformatics company founded in 2023 and headquartered at Embassy Manyata Business Park in Bengaluru, with a secondary office in S.G. Palya. The company sells AI/ML-enabled analytical services across six omics disciplines — genomic data analysis (WGS, WES, Hi-C, Bionano, GBS, single-cell, exosomal/cfDNA), proteomics (nano-flow LC-MS/MS, quantitative and PTM analysis), epigenomics (WGBS, RRBS, ChIP-Seq, ATAC-Seq, Hi-C), transcriptomics (WTS, small RNA, single-cell RNA-Seq), metagenomics (OTU-based taxonomic and functional profiling), and structural biology (protein structure prediction, molecular dynamics). Biogrithm's stated technology stack combines machine-learning algorithms with established sequencing and mass-spectrometry pipelines for variant calling, biomarker discovery, pathway analysis, and protein structure modeling, and the company is extending into laboratory software via BIOGLIMS, a Laboratory Information Management System under development.

The company operates with a horizontally segmented go-to-market targeting three primary buyer groups: academic/research institutions, clinicians and healthcare professionals, and pharmaceutical and biotech companies, plus a secondary segment of student researchers served through an internship pipeline. Distribution is sales-led and direct: enterprise and institutional buyers are reached through the company website, a self-serve service portal for project intake, and LinkedIn professional networking, with no third-party reseller or marketplace channel disclosed. Revenue is generated from project-based bioinformatics services, software development (including the BIOGLIMS platform and BIOGRITHM-branded software), training and internship programs, and recurring subscriptions or one-time software purchases referenced in the terms and conditions; no pricing tiers or contract values are publicly disclosed.

As of the most recent disclosure the company reports 19 employees, $12,000 in cumulative investments, 21 worldwide partners, 5 publications, and 25 ongoing research programs (12 bioinformatics services, 5 software, 8 internships). The company holds no disclosed patents, trademarks, or regulatory certifications beyond WCAG 2.1 AA website accessibility, has no disclosed revenue or ARR, and operates a single primary entity under Indian private-limited structure with one named executive, CEO and Co-Founder Ditto M Mohan.

Name

biogrithm

Legal name

Biogrithm Bioinformatics Company Pvt Ltd

Website

https://biogrithm.com

Company type

Private

Founded year

2023

Operating status

Operating

Short description

Biogrithm is an India-based bioinformatics company that delivers AI/ML-driven genomic, proteomic, epigenomic, transcriptomic, metagenomic, and structural-biology analytical services to researchers, clinicians, and pharmaceutical companies.

Ownership category

akta.pro rank

Product category

Bioinformatics Software & Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Software Publishers (5132), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372)

akta.pro primary industry

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

akta.pro secondary industries

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Microbiome & Metagenomics Services (HLAGANAH)

Keywords

• Bioinformatics data analysis
• Genomic sequencing services
• Multi-omics software platform
• AI drug discovery
• Precision medicine research

Headquarters

HQ city

Bengaluru

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Bioinformatics Services: Providing bioinformatics analytical services to researchers, clinicians, and pharmaceutical companies including genomic, proteomic, epigenomic, transcriptomic, metagenomic, and structural biology analysis services.
2. Bioinformatics Software: Sale of advanced bioinformatics software solutions designed to streamline workflow and extract insights from complex biological data. The company also develops BIOGLIMS (Biogrithm Laboratory Information Management System).
3. Training and Internship Programs: Bioinformatics internship training program for aspiring researchers and data enthusiasts covering genomic analysis, data visualization, and software development. Currently running 8 ongoing internship programs.
4. Software Subscriptions and One-time Purchases: Terms and conditions reference recurring subscriptions and one-time purchases as available payment models.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Biogrithm develops AI and machine learning-driven bioinformatics software and delivers data analysis services across six omics disciplines (genomics, proteomics, epigenomics, transcriptomics, metagenomics, and structural biology) for pharmaceutical, clinical, and academic research customers. The company also runs bioinformatics training and internship programs, and is developing BIOGLIMS, a Laboratory Information Management System, to support laboratory data workflows.

Product overview

Biogrithm is a bioinformatics software and services company offering AI-driven technology for healthcare and biological research. The portfolio consists of multiple specialized bioinformatics services (Proteomics Analysis, Epigenomics, Transcriptomics, Metagenomics Analysis, Structural Biology, and Genomic Data Analysis) delivered through an advanced software platform. These services leverage machine learning algorithms to process and analyze complex biological data. The company is also developing BIOGLIMS as a laboratory information management system to support data management workflows. The services are designed for researchers, clinicians, and pharmaceutical companies to extract meaningful insights from genomic, proteomic, and microbiome data for applications in drug discovery, cancer genomics, rare disease diagnosis, and personalized medicine.

Differentiator

Problem solved

Functional benefit

Products and services

• Genomic Data Analysis Comprehensive genomic data analysis service covering whole genome sequencing (WGS), whole exome sequencing (WES), genome finishing (Hi-C/Bionano), genotyping by sequencing (GBS), single cell genomics, and exosomal/cfDNA sequencing for variant calling, pathway analysis, and comparative genomics; designed for researchers, clinicians, and pharmaceutical companies.
• Proteomics Analysis Proteomics analysis service enabling researchers to upload data for advanced algorithmic decoding, covering protein identification, functional analysis, proteome profiling, quantitative proteomics, and PTM analysis (phosphorylation, glycosylation, acetylation); serves precision medicine biomarker discovery.
• Epigenomics Epigenomics service exploring DNA methylation, histone modifications, and chromatin accessibility (WGBS/RRBS, ChIP-Seq, MeDIP-Seq, ATAC-Seq, Hi-C proximity ligation, single-cell ATAC-Seq) to understand cellular processes, disease mechanisms, and personalized medicine applications.
• Transcriptomics RNA transcript analysis service including whole transcriptome sequencing (WTS), small RNA profiling, degradome/PARE sequencing, exosomal RNA-Seq, and single-cell RNA-Seq for gene expression profiling and regulatory network analysis.
• Metagenomics Analysis Analysis of collective microbial genomes enabling taxonomic profiling, functional annotation, and microbial diversity assessment using OTU clustering, phylogenetic classification, and diversity indices (ACE, Chao1, Shannon, Simpson).
• Structural Biology
• BIOGLIMS (Biogrithm Laboratory Information Management System) Laboratory Information Management System under development, intended to streamline laboratory workflows and manage biological research data efficiently for healthcare and research institutions.
• Bioinformatics Internship Training Program Hands-on training program for aspiring researchers and data enthusiasts offering instruction and project experience in genomic analysis, data visualization, software development, computational genomics, and biogrithm software production; runs 8 ongoing internship batches under industry expert guidance.

Quantifiable outcome

• 12 ongoing bioinformatics services research projects and 5 ongoing software research projects in progress
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature5 records

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• DNAnexus: Cloud-based bioinformatics platform serving pharma, clinical, and research customers with genomic and multi-omic data analysis tooling. Directly comparable to Biogrithm as a software + services platform targeting similar translational research buyers.
• Velsera (formerly Seven Bridges): Bioinformatics platform offering multi-omic analysis, pipeline orchestration, and clinical genomics tools. Comparable to Biogrithm in its multi-omics breadth and pharma/biotech customer focus.
• Genedata: Enterprise bioinformatics and LIMS software for pharma R&D and biologics development. Comparable to Biogrithm across both analytics services and the BIOGLIMS LIMS product direction.
• Partek: Genomics and transcriptomics analysis software used by researchers and clinicians. Overlaps directly with Biogrithm's transcriptomics, genomic, and single-cell analysis offerings.
• Genialis: AI-driven bioinformatics platform focused on multi-omic biomarker discovery and translational research. Comparable to Biogrithm in its AI/ML emphasis and pharma R&D customer orientation.

Broad incumbents

• QIAGEN Digital Insights: Bioinformatics and curated knowledge-base products for genomics, variant interpretation, and clinical research. Comparable as a broader incumbent in the same bioinformatics software category Biogrithm targets.
• Illumina: Sequencing instruments plus DRAGEN and BaseSpace bioinformatics software. Comparable as an incumbent offering integrated sequencing + bioinformatics solutions that Biogrithm's full-stack model must compete against.

Regional players

• Strand Life Sciences: India-based bioinformatics and clinical genomics company offering analytics services and software for hospitals and researchers. Comparable as a regional peer with similar offerings to Biogrithm in the Indian market.
• MedGenome: India and US-based genomics research and diagnostics company providing multi-omic and bioinformatics support. Comparable as an India-rooted peer with overlapping genomics services and pharma collaborations.

Emerging players

• Emedgene: AI-powered variant analysis and clinical genomics interpretation platform. Comparable as an emerging AI-native bioinformatics player serving clinical and research customers similar to Biogrithm's clinician segment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biogrithm-bioinformatics-company-pvt-ltd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about biogrithm